Skip to content

Patient Preference With Visicol Tablet Preparation for Colonoscopy

Patient Preference and Acceptance With Sodium Phosphate Tablet Preparation for Colonoscopy: A Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00318305
Enrollment
53
Registered
2006-04-26
Start date
2005-03-31
Completion date
2006-04-30
Last updated
2009-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preparation for Colonoscopy

Brief summary

The purpose of this study is to determine patient preference and acceptance of tablet sodium phosphate bowel preparation in patients who had polyethylene glycol (PEG) solution for their prior colonoscopy. This study will provide answers related to the patient preferences and their acceptance of this new method of bowel preparation.

Interventions

None listed

Sponsors

InKine Pharmaceutical
CollaboratorINDUSTRY
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Prior colonoscopy with PEG solution in the past one year * Must be able to swallow tablets

Exclusion criteria

* Patients below 18 years and above 100 years. * Congestive heart failure * Chronic renal failure * Pre-existing electrolyte disorder * Pre-existing mega-colon or a motility disorder. * Patients with pre-existing seizure disorder. * Patients scheduled for colonoscopy after 1:00 p.m. will be excluded from the study. * Pregnant or lactating women

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026